Cargando…
Oxadiazole-Containing Macrocyclic Peptides Potentiate Azole Activity against Pathogenic Candida Species
Opportunistic pathogens of the genus Candida reign as the leading cause of mycotic disease and are associated with mortality rates greater than 40%, even with antifungal intervention. This is in part due to the limited arsenal of antifungals available to treat systemic fungal infections. Azoles have...
Autores principales: | Revie, Nicole M., Robbins, Nicole, Whitesell, Luke, Frost, John R., Appavoo, Solomon D., Yudin, Andrei K., Cowen, Leah E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142304/ https://www.ncbi.nlm.nih.gov/pubmed/32269162 http://dx.doi.org/10.1128/mSphere.00256-20 |
Ejemplares similares
-
Construction of Candida albicans Strains with ATP-Analog-Sensitive Protein Kinase A and Hog1
por: Liu, Zhongle, et al.
Publicado: (2023) -
High-Throughput Chemical Screen Identifies a 2,5-Disubstituted Pyridine as an Inhibitor of Candida albicans Erg11
por: Du Bois, Antonia C., et al.
Publicado: (2022) -
Genetic Analysis of Candida auris Implicates Hsp90 in Morphogenesis and Azole Tolerance and Cdr1 in Azole Resistance
por: Kim, Sang Hu, et al.
Publicado: (2019) -
Erratum for Kim et al., “Genetic Analysis of Candida auris Implicates Hsp90 in Morphogenesis and Azole Tolerance and Cdr1 in Azole Resistance”
por: Kim, Sang Hu, et al.
Publicado: (2019) -
Global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal drugs
por: Mount, Harley O’Connor, et al.
Publicado: (2018)